Recently, Thalys Medical Technology was strongly recommended by MedTech Outlook and won the title of "Top Ten In Vitro Diagnostic Solution Providers in the Asia-Pacific Region in 2022". MedTech Outlook is an internationally authoritative professional media in the medical technology industry. Every year, it selects the top 10 top solution providers in the subdivision of global compliance. The purpose of the list is to help decision makers better explore many products on the market, which integrates the world's leading ideas, leading industry trends, solving industry challenges, and medical innovation technologies with high creativity and influence, product, and service providers.

Thalys Medical Technology grasps the opportunities in the IVD industry chain, and expands the market scale with the dual main business development strategy of "IVD intensive operation service + hospital SPD smart lean management". 

The combination of third-party independent laboratories, regional medical testing centers, and advanced diagnostic technology layout provides the company with endogenous driving force and helps the company explore sources of profit growth and the possibility of multi-level development.